- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE invests in ultrasound therapy
No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical
No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical Imaging. InSightec is developing an MRI-guided, high-intensity, focused ultrasound system as a possible replacement for some surgical procedures. Per the agreement, GEMS will invest $10 million in a combination of cash and equipment for 11.8% of InSightec's shares. GEMS will also convert its previous 5% holdings in InSightec into an additional 5% holding and receive warrants for the purchase of another 5% of InSightec shares for $3 million, exercisable for a period of three years.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
